National Hospital Organization Shibukawa Medical Center

Gunma 377-0280

1 studies enrolling now · 4 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, MAC Lung Disease, Multiple Myeloma, Mycobacterium Infections, Nontuberculous, Relapsed or Refractory Multiple Myeloma, Treatment Refractory MAC Lung Disease

Studies at this site

• A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma — Recruiting now
• A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure — Running, not enrolling
• A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma — Running, not enrolling
• ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension — Stopped early